. 2020 May 12;9(6):506–518. doi: 10.1530/EC-20-0113
This work is licensed under a Table 1.
Percentage of filopodia and/or lamellipodia-positive TPC-1, 8505c and NThyOri cells after the indicated treatments.
| Cells Treatment |
TPC-1 | 8505c | NThyOri |
|---|---|---|---|
| % | % | % | |
| Medium | 35 | 19 | 9 |
| Fb CMs | 78a | 52a | 17 |
| TPC-1 CMs | 33 | ||
| Fb-TPC-1 CMs | 61 | ||
| 8505c CMs | 22 | ||
| Fb-8505c CMs | 60b | ||
| NThyOri CMs | 12 | ||
| Fb-NThyOri CMs | 18 |
The number of cells with lamellipodia and/or filopodia were counted in ten (63X) randomly selected fields. P-values <0.05 (Fisher Exact test) are indicated as a for TPC-1 and 8505c cells treated with Fb CMs vs basal condition (Medium) and as b for 8505c cells treated with Fb-8505c CMs vs basal condition.
CMs, Conditioned media.